Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-30 @ 9:41 PM
Study NCT ID:
NCT01095835
Status:
COMPLETED
Last Update Posted:
2016-11-03
First Post:
2010-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-02
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-26
First Submit QC Date:
None
Study First Post Date:
2010-03-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-15
Results First Submit QC Date:
None
Results First Post Date:
2016-11-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-15
Last Update Post Date:
2016-11-03
Last Update Post Date Type:
ESTIMATED